NCT04759248
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04759248
Title Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer (ATREZZO)
Acronym ATREZZO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
H. Clínico San Cecilio de Granada Granada Andalusia Spain Details
Hospital del Mar Barcelona Barcelona 08003 Spain Details
Institut Català d'Oncologia Hospitalet L'Hospitalet de Llobregat Barcelona Spain Details
Hospital Universitario de Canarias Santa Cruz de Tenerife Canary Islands 38320 Spain Details
Complejo Hospitalario Universitario A Coruña (CHUAC) A Coruña La Coruña 15006 Spain Details
Hospital General Universitario de Alicante Alicante Spain Details
Hospital Clinic de Barcelona Barcelona Spain Details
Hospital Universitari Vall d' Hebron Barcelona Spain Details
Hospital San Pedro de Alcántara Cáceres Spain Details
Hospital de León León 24071 Spain Details
Hospital Universitario 12 de octubre Madrid Spain Details
Hospital Son Espases Palma de Mallorca Spain Details
Hospital Universitari Sant Joan de Reus Reus 43201 Spain Details
Hospital Universitario Virgen del Rocio Seville Spain Details
Hospital Clinico Universitario de Valencia Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field